<\/p>\n
The MedsBase Diabetes Starter Pack pairs metformin sustained-release 1000 mg<\/strong> (Glycomet SR by USV) with metformin + glimepiride combination 500 mg + 2 mg<\/strong> (Glycomet-GP) \u2014 the two most-prescribed first-line and step-up agents for newly-diagnosed type-2 diabetes per ADA, EASD, and NICE 2024 guidelines. Metformin SR provides the foundation glucose-lowering effect; the metformin-glimepiride combination adds insulin secretagogue activity for patients who need a stronger second-line agent. Supply tiers: 1, 3, or 6 months. Specialist-supervised use only.<\/p>\n<\/div>\n \ud83d\udce6 Every order is covered by our Reshipment Assurance Policy<\/strong><\/a> \u2014 if your parcel does not arrive within 20 business days, we reship it.<\/p>\n Our generic medications are sourced from WHO-GMP certified manufacturers and shipped worldwide in discreet, plain packaging \u2014 no medication name on the parcel exterior. Card payments are routed through a regulated processor (statement descriptors include a regulated card-payment processor \u2014 never “MedsBase” or any medication name). Crypto and SEPA bank transfer are also accepted. Every order is backed by our Reshipment Assurance Policy.<\/p>\n For newly-diagnosed type-2 diabetes, the standard ADA\/EASD pathway is: metformin first, escalate dose to 2000 mg\/day over 4\u20138 weeks, recheck HbA1c at 12 weeks. If HbA1c remains above target (typically > 7%) and no specific compelling indication points to SGLT-2 \/ GLP-1 (no established ASCVD, CKD, or HF), a sulfonylurea like glimepiride is the most-used affordable second-line in many parts of the world.<\/p>\n This pack covers both the foundation regimen and the step-up regimen in one shipment. Patients who tolerate metformin well at 2000 mg\/day can run on Glycomet SR alone (use the 6-month tier as a maintenance supply). Patients whose HbA1c remains elevated can step up by adding Glycomet-GP \u2014 typically replacing one of the metformin SR doses with the combination to keep total metformin dose roughly constant.<\/p>\n Best candidates:<\/strong><\/p>\n NOT appropriate for:<\/strong><\/p>\n Glycomet SR 1000 mg (metformin SR)<\/strong><\/p>\n Glycomet-GP 500 mg + 2 mg (when stepping up)<\/strong><\/p>\n Hypoglycaemia warning<\/strong><\/p>\n Glimepiride causes hypoglycaemia; metformin does not (when used alone). Once you add Glycomet-GP, you have a real hypoglycaemia risk for the first time. Symptoms: sweating, shaking, hunger, racing heart, blurred vision, confusion. Always carry fast-acting carbs<\/strong> (glucose tablets, juice, sugar). Older patients and those with renal impairment are at higher risk and may need lower glimepiride dosing.<\/p>\n<\/div>\n Combined metformin + glimepiride is well-studied \u2014 no clinically significant pharmacokinetic interaction. The combination has been a standard step-up regimen for 25+ years.<\/p>\n Watch for: B12 deficiency on long-term metformin (annual B12 check after 4+ years); contrast-imaging temporary hold (48 hours before and after IV contrast); alcohol limit of 1\u20132 drinks per occasion; weight changes (sulfonylureas modestly increase weight, metformin is weight-neutral); medication review at any new prescription (many drugs interact with sulfonylureas).<\/p>\nWhy order from MedsBase<\/h3>\n
What’s in the Diabetes Starter Pack<\/h2>\n
\n
Why combine these two products?<\/h2>\n
Who this pack is for<\/h2>\n
\n
\n
How to use the pack correctly<\/h2>\n
\n
\n
Combined-use safety<\/h2>\n
Monitoring schedule<\/h2>\n